SOLUBLE CD163 IS A BIOMARKER FOR CARDIOVASCULAR EVENT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
David, C. [1 ]
Costedoat-Chalumeau, N. [2 ]
Belhadi, D. [3 ]
Leguern, V. [2 ]
Laouenan, C. [3 ]
Boutten, A. [4 ]
Chezel, J. [1 ]
Morel, N. [2 ]
Mathian, A. [5 ]
Amoura, Z. [5 ]
Papo, T. [1 ]
Sacre, K. [1 ]
机构：
[1] Univ Paris Bichat, Med Interne, Paris, France
[2] Univ Paris Cochin, Med Interne, Paris, France
[3] Univ Paris Bichat, URC, Paris, France
[4] Univ Paris Bichat, Biochim, Paris, France
[5] Sorbonne Univ Pitie, Med Interne, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.19
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0450
引用
收藏
页码：1353 / 1353
页数：1
相关论文
共 50 条
  • [1] Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease
    David, C.
    Divard, G.
    Abbas, R.
    Escoubet, B.
    Chezel, J.
    Chauveheid, M. P.
    Rouzaud, D.
    Boutten, A.
    Papo, T.
    Dehoux, M.
    Sacre, K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2020, 49 (01) : 33 - 37
  • [2] Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease
    David, C.
    Divard, G. D.
    Abbas, R.
    Escoubet, B.
    Chezel, J.
    Chauveheid, M.
    Rouzaud, D.
    Boutten, A.
    Lecon-Malas, V.
    Papo, T.
    Dehoux, M.
    Sacre, K.
    CLINICA CHIMICA ACTA, 2019, 493 : S84 - S84
  • [3] Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study
    David, Clemence
    Costedoat-Chalumeau, Nathalie
    Belhadi, Drifa
    Laouenan, Cedric
    Boutten, Anne
    Chezel, Julie
    Rouzaud, Diane
    Dehoux, Monique
    Le Guern, Veronique
    Mathian, Alexis
    Chaves, Sebastien de Almeida
    Duhaut, Pierre
    Fain, Olivier
    Galicier, Lionel
    Ghillani-Dalbin, Pascale
    Kahn, Jean Emmanuel
    Morel, Nathalie
    Perard, Laurent
    Pha, Micheline
    Sarrot-Reynauld, Francoise
    Aumaitre, Olivier
    Chasset, Francois
    Limal, Nicolas
    Desmurs-Clavel, Helene
    Ackermann, Felix
    Amoura, Zahir
    Papo, Thomas
    Sacre, Karim
    JOURNAL OF INTERNAL MEDICINE, 2022, 292 (03) : 536 - 539
  • [4] Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus
    Nishino, A.
    Katsumata, Y.
    Kawasumi, H.
    Hirahara, S.
    Kawaguchi, Y.
    Yamanaka, H.
    LUPUS, 2019, 28 (08) : 986 - 994
  • [5] Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
    Frantz, Camelia
    Pezet, Sonia
    Avouac, Jerome
    Allanore, Yannick
    DISEASE MARKERS, 2018, 2018
  • [6] Soluble CD163 is a potential biomarker in systemic sclerosis
    Matsushita, Takashi
    Takehara, Kazuhiko
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (03) : 197 - 199
  • [7] SOLUBLE CD163 AS A POTENTIAL BIOMARKER IN SYSTEMIC SCLEROSIS
    Frantz, C.
    Pezet, S.
    Avouac, J.
    Allanore, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 98 - 98
  • [8] CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus
    Nakayama, Wakana
    Jinnin, Masatoshi
    Makino, Katsunari
    Kajihara, Ikko
    Makino, Takamitsu
    Fukushima, Satoshi
    Sakai, Keisuke
    Inoue, Yuji
    Ihn, Hironobu
    EUROPEAN JOURNAL OF DERMATOLOGY, 2012, 22 (04) : 512 - 517
  • [9] Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
    Huang, Yun-Ju
    Lin, Chiung-Hung
    Yang, Huang-Yu
    Luo, Shue-Fen
    Kuo, Chang-Fu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis
    Mejia-Vilet, Juan M.
    Zhang, Xiaolan L.
    Cruz, Cristino
    Cano-Verduzco, Mayra L.
    Shapiro, John P.
    Nagaraja, Haikady N.
    Morales-Buenrostro, Luis E.
    Rovin, Brad H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (06): : 1335 - 1347
12345